Rosita Kammler heads the Translational Research Coordination at the ETOP IBCSG Partners Foundation, a clinical and translational cancer research foundation that recently merged out of the ETOP (European Thoracic Oncology Platform) and IBCSG (International Breast Cancer Study Group). Her work has revolved around clinical trial biobanking, translational research coordination and project management for the past 20 years, and has gained extensive experience in enabling global translational research that accesses biobanks. She has provided leadership for designing, building and conducting the translational research programs and biobanks for IBCSG and ETOP, enabling state-of-the-art oncology translational research. She is responsible that the trial biosamples meet the objectives for quality, quantity, ethical use, to ensure the integrity of research data and analysis. These biobanks have been a critical resource for the more than 40 translational research studies conducted by ETOP IBCSG, or collaborators. She is responsible for the management and oversight of all translational research activities and biobanking activities conducted by IBCSG and ETOP in the course of prospective global clinical trials and retrospective biomarker analyses, including the ETOP Lungscape and Mesoscape iBiobanks. As newly nominated ESBB Advisor, Rosita Kammler supports the Executive Board of the European, Middle East and Africa Society for Biopreservation and Biobanking. She served for a term as ESBB Councilor starting in 2016, ESBB Vice-President 2018-2020, ESBB President 2020-2021, and ESBB Past President 2021-2022. She chairs the ESBB Sustainability Task Force, along with Lasse Boding, and serves as mentor of the ESBB GDPR and ELSI Working Group.
